AGAna Giménez

Ana Giménez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ana Giménez has a total of 156 co-authors. Here are the top co-authors by number of shared publications:

  • Tomás Franquet

    Radiology Department, Hospital de la Santa Creu i Sant Pau

    15 shared publications
  • Tomás Franquet

    Department of Radiology, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, Barcelona, Spain

    9 shared publications
  • Alberto Hidalgo

    Division of Clinical Hematology, Department of Radiology, Hospital de la Sant Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain

    6 shared publications
  • Pere Domingo

    Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

    6 shared publications
  • T. Franquet

    Sección de Radiología Torácica, Hospital de la Santa Creu i Sant Pau, Barcelona, España

    6 shared publications
  • Nestor L. Müller

    Department of Radiology, Vancouver Hospital and Health Sciences Center and University of British Columbia, Vancouver, BC V5Z 1M9, Canada

    4 shared publications

Latest Publications

  • Community-acquired Pneumonia

    by Tomás Franquet, Jose M. Brenes, Ana Giménez, Pere Domingo

    Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality worldwide, affecting individuals outside health care settings. Streptococcus pneumoniae is the predominant pathogen, although regional and socioeconomic factors significantly influence epidemiology, resistance patterns, and outcomes. Diagnosis relies on clinical evaluation supported by imaging, microbiology, and biomarkers, yet presentations are highly variable across age groups and comorbidities. Chest radiography remains the cornerstone for initial assessment, while high-resolution CT (HRCT) offers superior sensitivity for early detection and complications. Typical bacterial pathogens (eg, S. pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae ) produce lobar or bronchopneumonic consolidations, whereas atypical organisms ( Mycoplasma, Chlamydia, Legionella ) and viruses often yield diffuse ground-glass or interstitial patterns. Fungal and mycobacterial infections must also be considered, particularly in endemic regions. Radiologic-pathologic correlation is essential to differentiate CAP etiologies, guide management, and identify complications such as cavitation, empyema, or necrosis. Understanding these imaging patterns within global and clinical contexts is critical for improving diagnostic accuracy and optimizing patient outcomes.

  • Open Access

    Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC

    by Wolfgang Uter, S. Mark Wilkinson, Olivier Aerts, Andrea Bauer, Leopoldo Borrego, Richard Brans, Timo Buhl, Heinrich Dickel, Aleksandra Dugonik, Francesca Larese Filon, et al.

    Background: Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.Objectives: To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.Methods: Anonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.Results: In 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2–20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43–7.19)% and 6.62 (6.25–7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16–2.85]% vs. 1.59 [1.33–1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16–3.82]%), followed by 2‐hydroxyethyl methacrylate (2.32 [2.0–2.68]%).Conclusion: Ongoing surveillance on the prevalence of contact sensitization contributes to an up‐to‐date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe.


  • Human Oncoviruses and Thoracic Tumors: Understanding the Imaging Findings

    by Tomás Franquet, Teri J. Franks, Kyung Soo Lee, Edson Marchiori, Sandra Mazzini, Ana Giménez, Takeshi Johkoh, Junhun Cho, Jeffrey R. Galvin

    Various oncoviruses are implicated in approximately 12%–25% of all human cancers as uncommon consequences of the normal viral life cycle, and the clinical setting and imaging findings can provide c... Approximately 1.4 million virus-induced cancers occur annually, representing roughly 10% of the cancer burden worldwide. Seven oncogenic DNA and RNA viruses (ie, oncoviruses) are implicated in appr... Created with BioRender.com


  • Open Access

    Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT

    by Tomás Franquet, Ana Giménez, Loren Ketai, Sandra Mazzini, Andrea Rial, Virginia Pomar, Pere Domingo

    Objectives: The study reports our experience with paired inspiration/expiration thin-section computed tomographic (CT) scans in the follow-up of COVID-19 patients with persistent respiratory symptoms. Methods: From August 13, 2020, to May 31, 2021, 48 long-COVID patients with respiratory symptoms (27 men and 21 women; median age, 62.0 years; interquartile range: 54.0–69.0 years) underwent follow-up paired inspiration-expiration thin-section CT scans. Patient demographics, length of hospital stay, intensive care unit admission rate, and clinical and laboratory features of acute infection were also included. The scans were obtained on a median of 72.5 days after onset of symptoms (interquartile range: 58.5–86.5) and at least 30 days after hospital discharge. Thin-section CT findings included ground-glass opacity, mosaic attenuation pattern, consolidation, traction bronchiectasis, reticulation, parenchymal bands, bronchial wall thickening, and air trapping. We used a quantitative score to determine the degree of air trapping in the expiratory scans. Results: Parenchymal abnormality was found in 50% (24/48) of patients and included air trapping (37/48, 77%), ground-glass opacities (19/48, 40%), reticulation (18/48, 38%), parenchymal bands (15/48, 31%), traction bronchiectasis (9/48, 19%), mosaic attenuation pattern (9/48, 19%), bronchial wall thickening (6/48, 13%), and consolidation (2/48, 4%). The absence of air trapping was observed in 11/48 (23%), mild air trapping in 20/48 (42%), moderate in 13/48 (27%), and severe in 4/48 (8%). Independent predictors of air trapping were, in decreasing order of importance, gender (p = 0.0085), and age (p = 0.0182). Conclusions: Our results, in a limited number of patients, suggest that follow-up with paired inspiratory/expiratory CT in long-COVID patients with persistent respiratory symptoms commonly displays air trapping. Key Points: • Our experience indicates that paired inspiratory/expiratory CT in long-COVID patients with persistent respiratory symptoms commonly displays air trapping. • Iterative reconstruction and dose-reduction options are recommended for demonstrating air trapping in long-COVID patients.


  • El informe radiológico en patología intersticial pulmonar

    by A. Giménez, S. Mazzini, T. Franquet

  • Open Access

    Non-Infectious Granulomatous Lung Disease: Imaging Findings with Pathologic Correlation

    by Tomás Franquet, Teri J. Franks, Jeffrey R. Galvin, Edson Marchiori, Ana Giménez, Sandra Mazzini, Takeshi Johkoh, Kyung Soo Lee

    Franquet T, et al. Korean J Radiol. 2021 May;22:e69. https://doi.org/10.3348/kjr.2020.1082


  • Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach

    by Rodrigo Martino, Ana Garrido, Marta Santaliestra, Irene García-Cadenas, Silvana Novelli, Silvanna Daniella Saavedra, Albert Esquirol, Miquel Granell, Javier Briones, Carolina Moreno, et al.

    Broad-spectrum antifungal prophylaxis is currently considered the standard of care for adults with de novo AML for the prevention of invasive fungal infections (IFIs), especially invasive pulmonary aspergillosis (IPA). Because fluconazole has been used in our center as anti-yeast prophylaxis, we sought to analyze in detail the incidence of IFIs over a 17-year period, as well as their impact on outcome. A standardized protocol of patient management, including serum galactomannan screening and thoracic CT-guided diagnostic-driven antifungal therapy, was used in all patients. A total of 214 consecutive adults with de novo AML who were treated in 3 CETLAM (Grupo Cooperativo para el Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias) protocols from 2002 to 2018 were included. The 90-day incidence of any IFI (including possible cases) was 11% (95% CI 4–15%), most cases occurred during induction chemotherapy (8%, 95% CI 4–12%), and most cases were probable/proven IPA (8%, 95% CI 3–13%). Developing an IFI during induction and consolidation had no impact on 1-year survival. A case–control study with 23 cases of IPA and 69 controls identified induction/re-induction chemotherapy, chronic pulmonary disease and age > 60 years/poor baseline performance status as potential pretreatment risk factors. The current study proves that inpatient induction and consolidation chemotherapy for de novo AML can be given in areas with “a priori” high-burden of airborne molds with fluconazole prophylaxis, while the selective use of anti-mold prophylaxis in patients at very high risk may further reduce the incidence of IFI in this specific clinical scenario.


  • A novel bone suppression method that improves lung nodule detection

    by Jens von Berg, Stewart Young, Heike Carolus, Robin Wolz, Axel Saalbach, Alberto Hidalgo, Ana Giménez, Tomás Franquet


  • Nódulos pulmonares migratorios en paciente con colitis ulcerosa

    by Silvia Barril, Ana Rodrigo-Troyano, Ana Giménez, Oriol Sibila


  • Neumonías intersticiales idiopáticas

    by T. Franquet, A. Giménez